Abstract
Purpose
The aim of the study was to create novel mucoadhesive drug delivery systems by incorporating amphiphilic hydrophobically modified, thiolated and preactivated polymers (preactivated thiomers) into self-emulsifying drug delivery systems (SEDDS).
Methods
L-Cysteine methyl ester was covalently attached to the polymeric backbone of Pemulen TR-2 and preactivated using 2-mercaptonicotinic acid (2-MNA). These thiomers were incorporated in a concentration of 0.3% (w/v) into SEDDS. The size distribution and the zeta potential of the emulsions were evaluated by dynamic light scattering. Mucoadhesive properties of thiomers-SEDDS spiked with FDA (fluorescein diacetate) were examined utilizing rheological measurement, permeation studies and in vitro residence time study on porcine mucosa. Cell viability tests were additionally performed.
Results
734 ± 58 μmol L-Cysteine methyl ester and 562 ± 71 μmol 2-MNA could be attached per gram polymer of Pemulen TR-2. Emulsions exhibited a droplet size range between 180 and 270 nm. Blank SEDDS possessed a zeta potential value between −5.7 and −8.6 mV, whereas thiomers-SEDDS between −14.6 and −17.2 mV. Viscous modulus of thiomer and preactivated thiomer containing SEDDS-mucus mixture was 8-fold and 11-fold increased in comparison to reference. The amount of FDA permeated the mucus layer was 2-fold lower in case of thiomers-SEDDS compared to blank SEDDS. A prolonged residence time was observed for thiomers-SEDDS over 45 min. During cell viability studies no severe toxic effects were detected.
Conclusion
The novel developed SEDDS with incorporated thiomers might be a promising tool for mucoadhesive oral drug delivery.
Similar content being viewed by others
Abbreviations
- DTNB:
-
5,5´-Dithio-bis(2-nitrobenzoic acid
- EDAC:
-
1-Ethyl-3-(3- dimethylaminopropyl) carbodiimide hydrochloride
- FDA:
-
Fluorescein diacetate
- 2-MNA:
-
2-Mercaptonicotinic acid
- MTT:
-
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NHS:
-
N-hydroxysuccinimide
- SEDDS:
-
Self-emulsifying drug delivery systems
- TNBS:
-
2,4,6-Trinitrobenzene sulfonic acid
References
Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or Presystemic metabolism. J Pharm Sci. 1993;82(10):979–87.
Karamanidou T, Karidi K, Bourganis V, Kontonikola K, Kammona O, Kiparissides C. Effective incorporation of insulin in mucus permeating self-nanoemulsifying drug delivery systems. Eur J Pharm Biopharm. 2015;97(Pt A):223–9.
Bruno BJ, Miller GD, Lim CS. Basics and recent advances in peptide and protein drug delivery. Ther Deliv. 2013;4(11):1443–67.
Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods. 2000;44(1):235–49.
Albrecht K, Bernkop-Schnürch A. Thiomers: forms, functions and applications to nanomedicine. Nanomedicine (London, England). 2007;2(1):41–50.
Ijaz M, Bernkop-Schnürch A. Preactivated thiomers: their role in drug delivery. Expert Opin Drug Deliv. 2015;12(8):1269–81.
Nirosha M, Badarinath A, Hyndavi M, Prasad K, Naveen N, Anil Kumar B, et al. Recent advances in self-emulsifying drug delivery system. Int J Rev Life Sci. 2011;1(4):206–14.
Chatterjee B, Hamed Almurisi S, Ahmed Mahdi Dukhan A, Mandal UK, Sengupta P. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view. Drug Deliv. 2016:1–14.
Friedl H, Dünnhaupt S, Hintzen F, Waldner C, Parikh S, Pearson JP, et al. Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci. 2013;102(12):4406–13.
Valicherla GR, Dave KM, Syed AA, Riyazuddin M, Gupta AP, Singh A, et al. Formulation optimization of Docetaxel loaded self-emulsifying drug delivery system to enhance bioavailability and anti-tumor activity. Sci Report. 2016;6:26895.
Hintzen F, Perera G, Hauptstein S, Müller C, Laffleur F, Bernkop-Schnürch A. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm. 2014;472(1–2):20–6.
Sakloetsakun D, Dünnhaupt S, Barthelmes J, Perera G, Bernkop-Schnürch A. Combining two technologies: multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. Int J Biol Macromol. 2013;61:363–72.
Leonaviciute G, Trivic Adamovic N, Thanh Lam H, Rohrer J, Partenhauser A, Bernkop-Schnürch A. Self-emulsifying drug delivery systems (SEDDS): proof-of-concept how to make them mucoadhesive. Eur J Pharm Biopharm. 2017;112:51–7.
Bonengel S, Haupstein S, Perera G, Bernkop-Schnürch A. Thiolated and S-protected hydrophobically modified cross-linked poly(acrylic acid)--a new generation of multifunctional polymers. Eur J Pharm Biopharm. 2014;88(2):390–6.
Iqbal J, Shahnaz G, Dünnhaupt S, Müller C, Hintzen F, Bernkop-Schnürch A. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials. 2012;33(5):1528–35.
Müller C, Ma BN, Gust R, Bernkop-Schnürch A. Thiopyrazole preactivated chitosan: combining mucoadhesion and drug delivery. Acta Biomater. 2013;9(5):6585–93.
Rahmat D, Müller C, Barthelmes J, Shahnaz G, Martien R, Bernkop-Schnürch A. Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles. Eur J Pharm Biopharm. 2013;83(2):149–55.
Karwal R, Garg T, Rath G, Markandeywar TS. Current trends in self-emulsifying drug delivery systems (SEDDSs) to enhance the bioavailability of poorly water-soluble drugs. Crit Rev Ther Drug Carrier Syst. 2016;33(1):1–39.
Leonaviciute G, Bernkop-Schnürch A. Self-emulsifying drug delivery systems in oral (poly)peptide drug delivery. Expert Opin Drug Deliv. 2015;12(11):1703–16.
Bonengel S, Hauptstein S, Leonaviciute G, Griessinger J, Bernkop-Schnürch A. Thiolated alkyl-modified carbomers: novel excipients for mucoadhesive emulsions. Eur J Pharm Sci. 2015;75:123–30.
He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–66.
Friedl HE, Dünnhaupt S, Waldner C, Bernkop-Schnürch A. Preactivated thiomers for vaginal drug delivery vehicles. Biomaterials. 2013;34(32):7811–8.
Köllner S, Dünnhaupt S, Waldner C, Hauptstein S, Pereira de Sousa I, Bernkop-Schnürch A. Mucus permeating thiomer nanoparticles. Eur J Pharm Biopharm. 2015;97(Pt A):265–272.
Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 2001;47(1):39–54.
Bonengel S, Bernkop-Schnürch A. Thiomers--from bench to market. J Control Release. 2014;195:120–9.
Griesser J, Hetényi G, Moser M, Demarne F, Jannin V, Bernkop-Schnürch A. Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems. 2017 International Journal of Pharmaceutics (in press).
Acknowledgements and Disclosures
The research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 280,761.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hetényi, G., Griesser, J., Nardin, I. et al. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems. Pharm Res 34, 1171–1179 (2017). https://doi.org/10.1007/s11095-017-2131-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-017-2131-5